InvestorsHub Logo
Followers 1170
Posts 34538
Boards Moderated 0
Alias Born 03/26/2007

Re: None

Thursday, 05/13/2021 1:47:25 PM

Thursday, May 13, 2021 1:47:25 PM

Post# of 13742
Sounds or Seem like QNTA already got the FDA IND GreenLight...
https://finance.yahoo.com/news/medolife-rx-announces-extraction-facility-120000538.html

Medolife has been researching Escozine® as a potential treatment for COVID-19 in clinical research programs in both the United States and the DR. The Company has completed numerous safety and efficacy studies on the drug, and filed a final data set with the US Food and Drug Administration (FDA) as it relates to an Investigational New Drug (IND) filing on Escozine®.


The Company is in the process of registration for medical ethics committee approval to conduct double-blind placebo human studies on Escozine®, which would mark a substantial step forward in Escozine’s path toward worldwide registration and adoption.

Let's see an 8K release AH or tomorrow.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.